Scientists at Albert Einstein College of Medicine of Yeshiva University give birth to identified a small intracellular protein that helps cells commit suicide. The finding, reported as the “paper of the week” in the January 16th publish issue of the Logbook of Biological Chemistry, could be to drugs for combating cancer and other diseases characterized by overproduction of cells. The research was led by the late Dennis Shields, Ph.D., a professor in Einstein’s Department of Developmental and Molecular Biology for 30 years, who died unexpectedly in December.
In response to feature or as a natural part of aging, myriad cells undergo programmed suicide, also known as apoptosis. Cancer cells often become immortal and unsafe by developing the ability to cease apoptosis.
A decade ago apoptosis was kindness to be directed solely by the pith and mitochondria of cells. Dr. Shields’ laboratory was the first to show that a cellular organelle known as the Golgi apparatus also plays a capacity in apoptosis.
The Golgi enclose proteins and other substances made by cells and blunt them to their destination within the cell. A protein called p115 is brisk for maintaining the structure of the Golgi. In earlier experimentation, Dr. Shields’ grouping demonstrated that the Golgi’s p115 protein splits into two pieces early in apoptosis and that the smaller of these protein fragments 205 amino acids in length helps to continue the cell-suicide process.
In the present study, the Einstein researchers identified the smallest dominion of this p115 protein fragment that is required inasmuch as apoptosis: a peptide of moral 26 amino acids in length that exerts its apoptotic action by traveling to the nucleus.
“Dennis Shields was one-liner of our most memorable scientists,” says E. Richard Stanley, Ph.D., chairman of developmental and molecular biology at Einstein. “His efforts to uncover fundamental mechanisms governing how cells work has led to new ways of thinking about apoptosis, in particular, how the Golgi regulates this process.”
The paper, by Shaeri Mukherjee and Dennis Shields, is titled “Nuclear Import is Required for the Pro-apoptotic Job of the Golgi Protein p115″ and appeared in JBC Papers in Press on November 21, 2008 and in the January 16, 2009 print set forth. Additionally, the weekly chose the image from the publication for the cover and spotlighted the study’s first author, Shaeri Mukherjee, Ph.D., a former student in the laboratory of Dr. Shields.
About Albert Einstein College of Drug of Yeshiva University
Albert Einstein College of Medication of Yeshiva University is one of the nation’s premier centers fitted research, medical education and clinical examination. It is the adept in to some 2,000 faculty members, 750 M.D. students, 350 Ph.D. students (including 125 in combined M.D./Ph.D. programs) and 380 postdoctoral investigators. Pattern year, Einstein received more than $130 million in boost from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver blight, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental sense examination, neuroscience, cardiac disease, and initiatives to shorten and eliminate ethnic and folk form disparities. Through its wide-ranging affiliation network involving five hospital centers in the Bronx, Manhattan and Long Cay which includes Montefiore Medical Center, Einstein’s officially designated University Hospital the College runs Possibly man of the largest post-graduate medical training program in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training. For more information, please stop http://www.aecom.yu.edu.
Albert Einstein College of Medicine of Yeshiva University
1300 Morris Park Ave.
Bronx
NY 10461
United States
http://www.aecom.yu.edu